Cannabis Clinical Trials

By Matthew Bultman Law360 (January 11, 2019, 6:14 PM EST) — The Patent Trial and Appeal Board dipped its toe into the pool of marijuana-related inventions with a recent decision involving an epilepsy treatment patent, providing the cannabis industry a glimpse at… … read more at: https://www.law360.com/articles/1116813/3-takeaways-from-the-ptab-s-cannabis-experience

by

Time for a snap quiz. Without using Google or peeking, identify the public figure who made this statement: Federal and state laws (should) be changed to no longer make it a crime to possess marijuana for private use. Cue the theme from Jeopardy. Give up? It was President Richard M. Nixon. Old “Tricky Dick” may […]

by

NORFOLK, Va. (AP) — A research firm in Virginia says it has gotten a federal license to import high-quality extracts of marijuana for medical research. The Virginian-Pilot reported Wednesday that Sanyal Biotechnology will soon embark on a series of critical studies into treatment of various diseases and disorders. Sanyal CEO Rebecca Caffrey said the license […]

by

Last year, the America’s Food And Drug Administration (FDA) legalised a cannabidiol (CBD) oil, trademarked as Epidiolex, for the treatment of two severe forms of rare childhood epilepsy. Now available online and in health shops across the UK, the health chatter around this cannabis-based product is getting louder and more authoritative. But with cannabis still […]

by

Canopy Growth Corporation recently announced that its wholly-owned subsidiary, Spectrum Cannabis has partnered with the Ontario Long Term Care Association (OLTCA) by way of an unrestricted educational grant to pursue the development and implementation of a long-term care (LTC) medical cannabis pilot study and care pathway for utilization in Ontario long-term care homes. The six-month pilot aims […]

by

LINCOLN, Neb. (AP) – Most epilepsy patients taking cannabis-derived oil in a clinical trial at the University of Nebraska Medical Center continue to see improvement in their seizures. A study authorized by Nebraska lawmakers in 2015 has shown the majority of the 23 participating patients have experienced benefits from taking cannabidiol, commonly referred to as […]

by

LONDON–(BUSINESS WIRE)–Jan 10, 2019–EMMAC, the European independent medical cannabis company, is pleased to announce a research collaboration with Imperial College London to deliver a long-term comprehensive research programme designed to inform and shape the future of the medical cannabis therapeutic industry. The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to […]

by

‘+ ‘ ‘+__tnt.truncateStr(oAsset.title.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ ‘+__tnt.truncateStr(oAsset.summary.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ … read more at: http://www.messenger-inquirer.com/features/health/is-the-hype-about-cbd-real/article_c1ebdc05-d364-5a57-9671-6ce2b47582b4.html

by

LONDON–(BUSINESS WIRE)–EMMAC, the European independent medical cannabis company, is pleased to announce a research collaboration with Imperial College London to deliver a long-term comprehensive research programme designed to inform and shape the future of the medical cannabis therapeutic industry. The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical […]

by

A research firm in Virginia says it has gotten a federal license to import high-quality extracts of marijuana for medical research. The Virginian-Pilot reported Wednesday that Sanyal Biotechnology will soon embark on a series of critical studies into treatment of various diseases and disorders. Sanyal CEO Rebecca Caffrey said the license is the broadest ever […]

by